Novel anticancer compounds as efficient apoptotic and potential anti - proliferative drugs in genetically modified hepatocellular carcinoma cell models /
Mai Ahmed Saad Zaghloul
Novel anticancer compounds as efficient apoptotic and potential anti - proliferative drugs in genetically modified hepatocellular carcinoma cell models / Mai Ahmed Saad Zaghloul ; Supervised Ahmed Ihab Abdelaziz - Cairo : Mai Ahmed Saad Zaghloul , 2009 - 78 Leaves : charts , facsimiles ; 30cm
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Molecular Genetics
Hepatocellular Carcinoma is one of the severe malignancies with high incidence worldwide as reported to be ranked the sixth most common cancers[2] . Several studies have investigated the underlying pathogenesis of the disease and hypothesized that the interaction between the etiological factors (e.g. HCV, HBV, AFB and cirrhosis [7] and the hepatocytic genes result in functional (imbalance between pro - apoptotic and anti - apoptotic signaling) and structural genomic alterations(loss and gain of chromosomal regions resulting in deletion of tumor suppressor genes e.g, p53 and Rb genes) constituting the basis for HCC pathogenesis [8,44,189]
Novel anticancer compounds as efficient apoptotic and potential anti - proliferative drugs in genetically modified hepatocellular carcinoma cell models / Mai Ahmed Saad Zaghloul ; Supervised Ahmed Ihab Abdelaziz - Cairo : Mai Ahmed Saad Zaghloul , 2009 - 78 Leaves : charts , facsimiles ; 30cm
Thesis (M.Sc.) - German University - Faculty of Postgraduate Studies and Scientific Research - Department of Molecular Genetics
Hepatocellular Carcinoma is one of the severe malignancies with high incidence worldwide as reported to be ranked the sixth most common cancers[2] . Several studies have investigated the underlying pathogenesis of the disease and hypothesized that the interaction between the etiological factors (e.g. HCV, HBV, AFB and cirrhosis [7] and the hepatocytic genes result in functional (imbalance between pro - apoptotic and anti - apoptotic signaling) and structural genomic alterations(loss and gain of chromosomal regions resulting in deletion of tumor suppressor genes e.g, p53 and Rb genes) constituting the basis for HCC pathogenesis [8,44,189]